SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-23-002320
Filing Date
2023-11-09
Accepted
2023-11-09 17:11:25
Documents
70
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q qnrx-20230930x10q.htm   iXBRL 10-Q 1165819
2 EX-31.1 qnrx-20230930xex31d1.htm EX-31.1 12697
3 EX-31.2 qnrx-20230930xex31d2.htm EX-31.2 12820
4 EX-32.1 qnrx-20230930xex32d1.htm EX-32.1 6518
5 EX-32.2 qnrx-20230930xex32d2.htm EX-32.2 6567
  Complete submission text file 0001410578-23-002320.txt   5098387

Data Files

Seq Description Document Type Size
6 EX-101.SCH qnrx-20230930.xsd EX-101.SCH 47267
7 EX-101.CAL qnrx-20230930_cal.xml EX-101.CAL 34070
8 EX-101.DEF qnrx-20230930_def.xml EX-101.DEF 185227
9 EX-101.LAB qnrx-20230930_lab.xml EX-101.LAB 374918
10 EX-101.PRE qnrx-20230930_pre.xml EX-101.PRE 291243
64 EXTRACTED XBRL INSTANCE DOCUMENT qnrx-20230930x10q_htm.xml XML 663113
Mailing Address 23 HATA'AS STREET KFAR SABA L3 44425
Business Address 23 HATA'AS STREET KFAR SABA L3 44425 97299741444
Quoin Pharmaceuticals, Ltd. (Filer) CIK: 0001671502 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: 10-Q | Act: 34 | File No.: 001-37846 | Film No.: 231393719
SIC: 3841 Surgical & Medical Instruments & Apparatus